nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—ABCB1—melanoma	0.26	1	CbGaD
Morphine—CYP3A4—Temozolomide—melanoma	0.0642	0.284	CbGbCtD
Morphine—CYP2D6—Vemurafenib—melanoma	0.0553	0.245	CbGbCtD
Morphine—ABCB1—Dactinomycin—melanoma	0.039	0.173	CbGbCtD
Morphine—CYP3A4—Vemurafenib—melanoma	0.0352	0.156	CbGbCtD
Morphine—ABCB1—Docetaxel—melanoma	0.0202	0.0892	CbGbCtD
Morphine—CYP3A4—Docetaxel—melanoma	0.0121	0.0534	CbGbCtD
Morphine—Naloxone—TLR4—melanoma	0.00284	0.71	CrCbGaD
Morphine—Hyponatraemia—Docetaxel—melanoma	0.000514	0.00211	CcSEcCtD
Morphine—Visual impairment—Temozolomide—melanoma	0.000513	0.0021	CcSEcCtD
Morphine—Erythema—Dactinomycin—melanoma	0.000512	0.0021	CcSEcCtD
Morphine—Flushing—Carmustine—melanoma	0.000511	0.0021	CcSEcCtD
Morphine—Ill-defined disorder—Bleomycin—melanoma	0.000509	0.00209	CcSEcCtD
Morphine—Anaemia—Bleomycin—melanoma	0.000507	0.00208	CcSEcCtD
Morphine—Diarrhoea—Vemurafenib—melanoma	0.000506	0.00208	CcSEcCtD
Morphine—Eye disorder—Temozolomide—melanoma	0.000497	0.00204	CcSEcCtD
Morphine—Malaise—Bleomycin—melanoma	0.000495	0.00203	CcSEcCtD
Morphine—Flushing—Temozolomide—melanoma	0.000494	0.00203	CcSEcCtD
Morphine—Leukopenia—Bleomycin—melanoma	0.000491	0.00202	CcSEcCtD
Morphine—Dizziness—Vemurafenib—melanoma	0.000489	0.00201	CcSEcCtD
Morphine—Angiopathy—Temozolomide—melanoma	0.000483	0.00198	CcSEcCtD
Morphine—Mental disorder—Carmustine—melanoma	0.000482	0.00198	CcSEcCtD
Morphine—Ataxia—Docetaxel—melanoma	0.000481	0.00197	CcSEcCtD
Morphine—Mediastinal disorder—Temozolomide—melanoma	0.00048	0.00197	CcSEcCtD
Morphine—Malnutrition—Carmustine—melanoma	0.000479	0.00197	CcSEcCtD
Morphine—Erythema—Carmustine—melanoma	0.000479	0.00197	CcSEcCtD
Morphine—Cough—Bleomycin—melanoma	0.000479	0.00197	CcSEcCtD
Morphine—Chills—Temozolomide—melanoma	0.000477	0.00196	CcSEcCtD
Morphine—Dehydration—Docetaxel—melanoma	0.000476	0.00195	CcSEcCtD
Morphine—Ill-defined disorder—Dactinomycin—melanoma	0.000475	0.00195	CcSEcCtD
Morphine—Anaemia—Dactinomycin—melanoma	0.000473	0.00194	CcSEcCtD
Morphine—Liver function test abnormal—Docetaxel—melanoma	0.000472	0.00194	CcSEcCtD
Morphine—Vomiting—Vemurafenib—melanoma	0.00047	0.00193	CcSEcCtD
Morphine—Dry skin—Docetaxel—melanoma	0.000469	0.00192	CcSEcCtD
Morphine—Chest pain—Bleomycin—melanoma	0.000467	0.00192	CcSEcCtD
Morphine—Orthostatic hypotension—Docetaxel—melanoma	0.000467	0.00192	CcSEcCtD
Morphine—Abdominal pain upper—Docetaxel—melanoma	0.000467	0.00192	CcSEcCtD
Morphine—Rash—Vemurafenib—melanoma	0.000466	0.00191	CcSEcCtD
Morphine—Mental disorder—Temozolomide—melanoma	0.000466	0.00191	CcSEcCtD
Morphine—Dermatitis—Vemurafenib—melanoma	0.000466	0.00191	CcSEcCtD
Morphine—Naltrexone—ABCB1—melanoma	0.000465	0.116	CrCbGaD
Morphine—Back pain—Carmustine—melanoma	0.000464	0.0019	CcSEcCtD
Morphine—Headache—Vemurafenib—melanoma	0.000463	0.0019	CcSEcCtD
Morphine—Erythema—Temozolomide—melanoma	0.000463	0.0019	CcSEcCtD
Morphine—Malnutrition—Temozolomide—melanoma	0.000463	0.0019	CcSEcCtD
Morphine—Breast disorder—Docetaxel—melanoma	0.000462	0.0019	CcSEcCtD
Morphine—Discomfort—Bleomycin—melanoma	0.000462	0.0019	CcSEcCtD
Morphine—Malaise—Dactinomycin—melanoma	0.000462	0.0019	CcSEcCtD
Morphine—Cramp muscle—Docetaxel—melanoma	0.000461	0.00189	CcSEcCtD
Morphine—Leukopenia—Dactinomycin—melanoma	0.000458	0.00188	CcSEcCtD
Morphine—Nasopharyngitis—Docetaxel—melanoma	0.000457	0.00188	CcSEcCtD
Morphine—Dysgeusia—Temozolomide—melanoma	0.000454	0.00186	CcSEcCtD
Morphine—Confusional state—Bleomycin—melanoma	0.000452	0.00185	CcSEcCtD
Morphine—Vision blurred—Carmustine—melanoma	0.000452	0.00185	CcSEcCtD
Morphine—Tremor—Carmustine—melanoma	0.000449	0.00184	CcSEcCtD
Morphine—Oedema—Bleomycin—melanoma	0.000448	0.00184	CcSEcCtD
Morphine—Anaphylactic shock—Bleomycin—melanoma	0.000448	0.00184	CcSEcCtD
Morphine—Back pain—Temozolomide—melanoma	0.000448	0.00184	CcSEcCtD
Morphine—Infection—Bleomycin—melanoma	0.000445	0.00183	CcSEcCtD
Morphine—Anaemia—Carmustine—melanoma	0.000443	0.00182	CcSEcCtD
Morphine—Dysphagia—Docetaxel—melanoma	0.000442	0.00181	CcSEcCtD
Morphine—Agitation—Carmustine—melanoma	0.00044	0.00181	CcSEcCtD
Morphine—Nausea—Vemurafenib—melanoma	0.000439	0.0018	CcSEcCtD
Morphine—Thrombocytopenia—Bleomycin—melanoma	0.000439	0.0018	CcSEcCtD
Morphine—Vision blurred—Temozolomide—melanoma	0.000436	0.00179	CcSEcCtD
Morphine—Bronchospasm—Docetaxel—melanoma	0.000435	0.00178	CcSEcCtD
Morphine—Tremor—Temozolomide—melanoma	0.000434	0.00178	CcSEcCtD
Morphine—Discomfort—Dactinomycin—melanoma	0.000431	0.00177	CcSEcCtD
Morphine—Ill-defined disorder—Temozolomide—melanoma	0.00043	0.00176	CcSEcCtD
Morphine—Leukopenia—Carmustine—melanoma	0.000429	0.00176	CcSEcCtD
Morphine—Anaemia—Temozolomide—melanoma	0.000428	0.00176	CcSEcCtD
Morphine—Anorexia—Bleomycin—melanoma	0.000427	0.00175	CcSEcCtD
Morphine—Agitation—Temozolomide—melanoma	0.000426	0.00175	CcSEcCtD
Morphine—Hypotension—Bleomycin—melanoma	0.000419	0.00172	CcSEcCtD
Morphine—Oedema—Dactinomycin—melanoma	0.000418	0.00172	CcSEcCtD
Morphine—Malaise—Temozolomide—melanoma	0.000418	0.00171	CcSEcCtD
Morphine—Vertigo—Temozolomide—melanoma	0.000416	0.00171	CcSEcCtD
Morphine—Convulsion—Carmustine—melanoma	0.000415	0.0017	CcSEcCtD
Morphine—Infection—Dactinomycin—melanoma	0.000415	0.0017	CcSEcCtD
Morphine—Leukopenia—Temozolomide—melanoma	0.000415	0.0017	CcSEcCtD
Morphine—Hypertension—Carmustine—melanoma	0.000414	0.0017	CcSEcCtD
Morphine—Palpitations—Temozolomide—melanoma	0.000409	0.00168	CcSEcCtD
Morphine—Thrombocytopenia—Dactinomycin—melanoma	0.000409	0.00168	CcSEcCtD
Morphine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000408	0.00168	CcSEcCtD
Morphine—Chest pain—Carmustine—melanoma	0.000408	0.00167	CcSEcCtD
Morphine—Anxiety—Carmustine—melanoma	0.000407	0.00167	CcSEcCtD
Morphine—Cough—Temozolomide—melanoma	0.000404	0.00166	CcSEcCtD
Morphine—Paraesthesia—Bleomycin—melanoma	0.000402	0.00165	CcSEcCtD
Morphine—Convulsion—Temozolomide—melanoma	0.000401	0.00165	CcSEcCtD
Morphine—Weight decreased—Docetaxel—melanoma	0.0004	0.00164	CcSEcCtD
Morphine—Hypertension—Temozolomide—melanoma	0.0004	0.00164	CcSEcCtD
Morphine—Dyspnoea—Bleomycin—melanoma	0.0004	0.00164	CcSEcCtD
Morphine—Anorexia—Dactinomycin—melanoma	0.000398	0.00164	CcSEcCtD
Morphine—Confusional state—Carmustine—melanoma	0.000394	0.00162	CcSEcCtD
Morphine—Arthralgia—Temozolomide—melanoma	0.000394	0.00162	CcSEcCtD
Morphine—Anxiety—Temozolomide—melanoma	0.000393	0.00161	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000392	0.00161	CcSEcCtD
Morphine—Oedema—Carmustine—melanoma	0.000391	0.00161	CcSEcCtD
Morphine—Discomfort—Temozolomide—melanoma	0.00039	0.0016	CcSEcCtD
Morphine—Decreased appetite—Bleomycin—melanoma	0.00039	0.0016	CcSEcCtD
Morphine—Infection—Carmustine—melanoma	0.000389	0.0016	CcSEcCtD
Morphine—Renal failure—Docetaxel—melanoma	0.000387	0.00159	CcSEcCtD
Morphine—Dry mouth—Temozolomide—melanoma	0.000386	0.00158	CcSEcCtD
Morphine—Stomatitis—Docetaxel—melanoma	0.000384	0.00158	CcSEcCtD
Morphine—Pain—Bleomycin—melanoma	0.000383	0.00157	CcSEcCtD
Morphine—Conjunctivitis—Docetaxel—melanoma	0.000383	0.00157	CcSEcCtD
Morphine—Thrombocytopenia—Carmustine—melanoma	0.000383	0.00157	CcSEcCtD
Morphine—Tachycardia—Carmustine—melanoma	0.000382	0.00157	CcSEcCtD
Morphine—Confusional state—Temozolomide—melanoma	0.000381	0.00156	CcSEcCtD
Morphine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000381	0.00156	CcSEcCtD
Morphine—Oedema—Temozolomide—melanoma	0.000378	0.00155	CcSEcCtD
Morphine—Anaphylactic shock—Temozolomide—melanoma	0.000378	0.00155	CcSEcCtD
Morphine—Infection—Temozolomide—melanoma	0.000376	0.00154	CcSEcCtD
Morphine—Anorexia—Carmustine—melanoma	0.000373	0.00153	CcSEcCtD
Morphine—Hepatobiliary disease—Docetaxel—melanoma	0.000373	0.00153	CcSEcCtD
Morphine—Nervous system disorder—Temozolomide—melanoma	0.000371	0.00152	CcSEcCtD
Morphine—Thrombocytopenia—Temozolomide—melanoma	0.00037	0.00152	CcSEcCtD
Morphine—Feeling abnormal—Bleomycin—melanoma	0.000369	0.00152	CcSEcCtD
Morphine—Skin disorder—Temozolomide—melanoma	0.000367	0.00151	CcSEcCtD
Morphine—Hypotension—Carmustine—melanoma	0.000366	0.0015	CcSEcCtD
Morphine—Hyperhidrosis—Temozolomide—melanoma	0.000365	0.0015	CcSEcCtD
Morphine—Decreased appetite—Dactinomycin—melanoma	0.000363	0.00149	CcSEcCtD
Morphine—Fatigue—Dactinomycin—melanoma	0.00036	0.00148	CcSEcCtD
Morphine—Anorexia—Temozolomide—melanoma	0.00036	0.00148	CcSEcCtD
Morphine—Pain—Dactinomycin—melanoma	0.000357	0.00147	CcSEcCtD
Morphine—Musculoskeletal discomfort—Carmustine—melanoma	0.000356	0.00146	CcSEcCtD
Morphine—Urticaria—Bleomycin—melanoma	0.000356	0.00146	CcSEcCtD
Morphine—Naloxone—ALB—melanoma	0.000355	0.0887	CrCbGaD
Morphine—Rhinitis—Docetaxel—melanoma	0.000355	0.00146	CcSEcCtD
Morphine—Body temperature increased—Bleomycin—melanoma	0.000354	0.00145	CcSEcCtD
Morphine—Hepatitis—Docetaxel—melanoma	0.000354	0.00145	CcSEcCtD
Morphine—Insomnia—Carmustine—melanoma	0.000354	0.00145	CcSEcCtD
Morphine—Hypoaesthesia—Docetaxel—melanoma	0.000352	0.00145	CcSEcCtD
Morphine—Paraesthesia—Carmustine—melanoma	0.000351	0.00144	CcSEcCtD
Morphine—Urinary tract disorder—Docetaxel—melanoma	0.000349	0.00143	CcSEcCtD
Morphine—Dyspnoea—Carmustine—melanoma	0.000349	0.00143	CcSEcCtD
Morphine—Oedema peripheral—Docetaxel—melanoma	0.000349	0.00143	CcSEcCtD
Morphine—Somnolence—Carmustine—melanoma	0.000348	0.00143	CcSEcCtD
Morphine—Connective tissue disorder—Docetaxel—melanoma	0.000348	0.00143	CcSEcCtD
Morphine—Urethral disorder—Docetaxel—melanoma	0.000347	0.00142	CcSEcCtD
Morphine—Feeling abnormal—Dactinomycin—melanoma	0.000344	0.00141	CcSEcCtD
Morphine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000344	0.00141	CcSEcCtD
Morphine—Insomnia—Temozolomide—melanoma	0.000342	0.0014	CcSEcCtD
Morphine—Gastrointestinal pain—Dactinomycin—melanoma	0.000342	0.0014	CcSEcCtD
Morphine—Visual impairment—Docetaxel—melanoma	0.000341	0.0014	CcSEcCtD
Morphine—Decreased appetite—Carmustine—melanoma	0.00034	0.0014	CcSEcCtD
Morphine—Paraesthesia—Temozolomide—melanoma	0.000339	0.00139	CcSEcCtD
Morphine—Naloxone—ABCB1—melanoma	0.000339	0.0847	CrCbGaD
Morphine—Gastrointestinal disorder—Carmustine—melanoma	0.000338	0.00139	CcSEcCtD
Morphine—Dyspnoea—Temozolomide—melanoma	0.000337	0.00138	CcSEcCtD
Morphine—Somnolence—Temozolomide—melanoma	0.000336	0.00138	CcSEcCtD
Morphine—Pain—Carmustine—melanoma	0.000334	0.00137	CcSEcCtD
Morphine—Constipation—Carmustine—melanoma	0.000334	0.00137	CcSEcCtD
Morphine—Dyspepsia—Temozolomide—melanoma	0.000333	0.00137	CcSEcCtD
Morphine—Eye disorder—Docetaxel—melanoma	0.000331	0.00136	CcSEcCtD
Morphine—Body temperature increased—Dactinomycin—melanoma	0.00033	0.00136	CcSEcCtD
Morphine—Abdominal pain—Dactinomycin—melanoma	0.00033	0.00136	CcSEcCtD
Morphine—Hypersensitivity—Bleomycin—melanoma	0.00033	0.00136	CcSEcCtD
Morphine—Decreased appetite—Temozolomide—melanoma	0.000329	0.00135	CcSEcCtD
Morphine—Flushing—Docetaxel—melanoma	0.000328	0.00135	CcSEcCtD
Morphine—Gastrointestinal disorder—Temozolomide—melanoma	0.000326	0.00134	CcSEcCtD
Morphine—Fatigue—Temozolomide—melanoma	0.000326	0.00134	CcSEcCtD
Morphine—Constipation—Temozolomide—melanoma	0.000323	0.00133	CcSEcCtD
Morphine—Pain—Temozolomide—melanoma	0.000323	0.00133	CcSEcCtD
Morphine—Feeling abnormal—Carmustine—melanoma	0.000322	0.00132	CcSEcCtD
Morphine—Asthenia—Bleomycin—melanoma	0.000322	0.00132	CcSEcCtD
Morphine—Angiopathy—Docetaxel—melanoma	0.000321	0.00132	CcSEcCtD
Morphine—Gastrointestinal pain—Carmustine—melanoma	0.00032	0.00131	CcSEcCtD
Morphine—Mediastinal disorder—Docetaxel—melanoma	0.000319	0.00131	CcSEcCtD
Morphine—Chills—Docetaxel—melanoma	0.000317	0.0013	CcSEcCtD
Morphine—Pruritus—Bleomycin—melanoma	0.000317	0.0013	CcSEcCtD
Morphine—Feeling abnormal—Temozolomide—melanoma	0.000311	0.00128	CcSEcCtD
Morphine—Mental disorder—Docetaxel—melanoma	0.00031	0.00127	CcSEcCtD
Morphine—Body temperature increased—Carmustine—melanoma	0.000309	0.00127	CcSEcCtD
Morphine—Abdominal pain—Carmustine—melanoma	0.000309	0.00127	CcSEcCtD
Morphine—Gastrointestinal pain—Temozolomide—melanoma	0.000309	0.00127	CcSEcCtD
Morphine—Malnutrition—Docetaxel—melanoma	0.000308	0.00126	CcSEcCtD
Morphine—Erythema—Docetaxel—melanoma	0.000308	0.00126	CcSEcCtD
Morphine—Hypersensitivity—Dactinomycin—melanoma	0.000308	0.00126	CcSEcCtD
Morphine—Dysgeusia—Docetaxel—melanoma	0.000302	0.00124	CcSEcCtD
Morphine—Urticaria—Temozolomide—melanoma	0.0003	0.00123	CcSEcCtD
Morphine—Asthenia—Dactinomycin—melanoma	0.0003	0.00123	CcSEcCtD
Morphine—Body temperature increased—Temozolomide—melanoma	0.000299	0.00123	CcSEcCtD
Morphine—Abdominal pain—Temozolomide—melanoma	0.000299	0.00123	CcSEcCtD
Morphine—Back pain—Docetaxel—melanoma	0.000298	0.00122	CcSEcCtD
Morphine—Muscle spasms—Docetaxel—melanoma	0.000296	0.00122	CcSEcCtD
Morphine—Hypersensitivity—Carmustine—melanoma	0.000288	0.00118	CcSEcCtD
Morphine—Diarrhoea—Dactinomycin—melanoma	0.000286	0.00117	CcSEcCtD
Morphine—Vomiting—Bleomycin—melanoma	0.000285	0.00117	CcSEcCtD
Morphine—Anaemia—Docetaxel—melanoma	0.000285	0.00117	CcSEcCtD
Morphine—Rash—Bleomycin—melanoma	0.000283	0.00116	CcSEcCtD
Morphine—Dermatitis—Bleomycin—melanoma	0.000282	0.00116	CcSEcCtD
Morphine—Asthenia—Carmustine—melanoma	0.000281	0.00115	CcSEcCtD
Morphine—Hypersensitivity—Temozolomide—melanoma	0.000278	0.00114	CcSEcCtD
Morphine—Syncope—Docetaxel—melanoma	0.000276	0.00113	CcSEcCtD
Morphine—Leukopenia—Docetaxel—melanoma	0.000276	0.00113	CcSEcCtD
Morphine—Palpitations—Docetaxel—melanoma	0.000272	0.00112	CcSEcCtD
Morphine—Asthenia—Temozolomide—melanoma	0.000271	0.00111	CcSEcCtD
Morphine—Loss of consciousness—Docetaxel—melanoma	0.000271	0.00111	CcSEcCtD
Morphine—Cough—Docetaxel—melanoma	0.000269	0.0011	CcSEcCtD
Morphine—Diarrhoea—Carmustine—melanoma	0.000268	0.0011	CcSEcCtD
Morphine—Pruritus—Temozolomide—melanoma	0.000267	0.0011	CcSEcCtD
Morphine—Convulsion—Docetaxel—melanoma	0.000267	0.0011	CcSEcCtD
Morphine—Nausea—Bleomycin—melanoma	0.000266	0.00109	CcSEcCtD
Morphine—Hypertension—Docetaxel—melanoma	0.000266	0.00109	CcSEcCtD
Morphine—Vomiting—Dactinomycin—melanoma	0.000266	0.00109	CcSEcCtD
Morphine—Rash—Dactinomycin—melanoma	0.000264	0.00108	CcSEcCtD
Morphine—Arthralgia—Docetaxel—melanoma	0.000262	0.00108	CcSEcCtD
Morphine—Chest pain—Docetaxel—melanoma	0.000262	0.00108	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00026	0.00107	CcSEcCtD
Morphine—Dizziness—Carmustine—melanoma	0.000259	0.00106	CcSEcCtD
Morphine—Diarrhoea—Temozolomide—melanoma	0.000259	0.00106	CcSEcCtD
Morphine—Dry mouth—Docetaxel—melanoma	0.000256	0.00105	CcSEcCtD
Morphine—Confusional state—Docetaxel—melanoma	0.000253	0.00104	CcSEcCtD
Morphine—Anaphylactic shock—Docetaxel—melanoma	0.000251	0.00103	CcSEcCtD
Morphine—Oedema—Docetaxel—melanoma	0.000251	0.00103	CcSEcCtD
Morphine—Dizziness—Temozolomide—melanoma	0.00025	0.00103	CcSEcCtD
Morphine—Infection—Docetaxel—melanoma	0.00025	0.00103	CcSEcCtD
Morphine—Vomiting—Carmustine—melanoma	0.000249	0.00102	CcSEcCtD
Morphine—Nausea—Dactinomycin—melanoma	0.000248	0.00102	CcSEcCtD
Morphine—Shock—Docetaxel—melanoma	0.000247	0.00102	CcSEcCtD
Morphine—Rash—Carmustine—melanoma	0.000247	0.00101	CcSEcCtD
Morphine—Nervous system disorder—Docetaxel—melanoma	0.000247	0.00101	CcSEcCtD
Morphine—Dermatitis—Carmustine—melanoma	0.000246	0.00101	CcSEcCtD
Morphine—Thrombocytopenia—Docetaxel—melanoma	0.000246	0.00101	CcSEcCtD
Morphine—Tachycardia—Docetaxel—melanoma	0.000245	0.00101	CcSEcCtD
Morphine—Headache—Carmustine—melanoma	0.000245	0.00101	CcSEcCtD
Morphine—Skin disorder—Docetaxel—melanoma	0.000244	0.001	CcSEcCtD
Morphine—Vomiting—Temozolomide—melanoma	0.00024	0.000987	CcSEcCtD
Morphine—Anorexia—Docetaxel—melanoma	0.00024	0.000984	CcSEcCtD
Morphine—Rash—Temozolomide—melanoma	0.000238	0.000978	CcSEcCtD
Morphine—Dermatitis—Temozolomide—melanoma	0.000238	0.000977	CcSEcCtD
Morphine—Headache—Temozolomide—melanoma	0.000237	0.000972	CcSEcCtD
Morphine—Hypotension—Docetaxel—melanoma	0.000235	0.000964	CcSEcCtD
Morphine—Nausea—Carmustine—melanoma	0.000232	0.000954	CcSEcCtD
Morphine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000229	0.00094	CcSEcCtD
Morphine—Insomnia—Docetaxel—melanoma	0.000227	0.000933	CcSEcCtD
Morphine—Paraesthesia—Docetaxel—melanoma	0.000226	0.000927	CcSEcCtD
Morphine—Nausea—Temozolomide—melanoma	0.000225	0.000922	CcSEcCtD
Morphine—Dyspnoea—Docetaxel—melanoma	0.000224	0.00092	CcSEcCtD
Morphine—Somnolence—Docetaxel—melanoma	0.000223	0.000917	CcSEcCtD
Morphine—Dyspepsia—Docetaxel—melanoma	0.000221	0.000908	CcSEcCtD
Morphine—Decreased appetite—Docetaxel—melanoma	0.000219	0.000897	CcSEcCtD
Morphine—Gastrointestinal disorder—Docetaxel—melanoma	0.000217	0.000891	CcSEcCtD
Morphine—Fatigue—Docetaxel—melanoma	0.000217	0.00089	CcSEcCtD
Morphine—Pain—Docetaxel—melanoma	0.000215	0.000882	CcSEcCtD
Morphine—Constipation—Docetaxel—melanoma	0.000215	0.000882	CcSEcCtD
Morphine—Feeling abnormal—Docetaxel—melanoma	0.000207	0.00085	CcSEcCtD
Morphine—Gastrointestinal pain—Docetaxel—melanoma	0.000206	0.000844	CcSEcCtD
Morphine—Body temperature increased—Docetaxel—melanoma	0.000199	0.000816	CcSEcCtD
Morphine—Abdominal pain—Docetaxel—melanoma	0.000199	0.000816	CcSEcCtD
Morphine—Hypersensitivity—Docetaxel—melanoma	0.000185	0.00076	CcSEcCtD
Morphine—Asthenia—Docetaxel—melanoma	0.00018	0.00074	CcSEcCtD
Morphine—Pruritus—Docetaxel—melanoma	0.000178	0.00073	CcSEcCtD
Morphine—Diarrhoea—Docetaxel—melanoma	0.000172	0.000706	CcSEcCtD
Morphine—Dizziness—Docetaxel—melanoma	0.000166	0.000682	CcSEcCtD
Morphine—Vomiting—Docetaxel—melanoma	0.00016	0.000656	CcSEcCtD
Morphine—Rash—Docetaxel—melanoma	0.000158	0.000651	CcSEcCtD
Morphine—Dermatitis—Docetaxel—melanoma	0.000158	0.00065	CcSEcCtD
Morphine—Headache—Docetaxel—melanoma	0.000157	0.000646	CcSEcCtD
Morphine—Nausea—Docetaxel—melanoma	0.000149	0.000613	CcSEcCtD
Morphine—OPRK1—Signaling Pathways—FN1—melanoma	1.43e-05	5.39e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1—melanoma	1.43e-05	5.39e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—MAPK1—melanoma	1.43e-05	5.36e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—melanoma	1.43e-05	5.36e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CG—melanoma	1.42e-05	5.33e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNA11—melanoma	1.41e-05	5.31e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOTCH1—melanoma	1.4e-05	5.27e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—melanoma	1.4e-05	5.26e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAP2K1—melanoma	1.38e-05	5.21e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PHGDH—melanoma	1.38e-05	5.2e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LUM—melanoma	1.38e-05	5.2e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2—melanoma	1.38e-05	5.19e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—FASN—melanoma	1.38e-05	5.19e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TERT—melanoma	1.38e-05	5.17e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CD—melanoma	1.38e-05	5.17e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CD80—melanoma	1.37e-05	5.17e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RAC1—melanoma	1.37e-05	5.16e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KIT—melanoma	1.37e-05	5.16e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CG—melanoma	1.37e-05	5.16e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APC—melanoma	1.37e-05	5.16e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—NRAS—melanoma	1.37e-05	5.16e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARG—melanoma	1.37e-05	5.15e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	1.36e-05	5.12e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—melanoma	1.36e-05	5.11e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC5A5—melanoma	1.36e-05	5.11e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGF—melanoma	1.36e-05	5.1e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HPSE—melanoma	1.36e-05	5.1e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—melanoma	1.35e-05	5.06e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CB—melanoma	1.34e-05	5.03e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.33e-05	5.02e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CUBN—melanoma	1.33e-05	5e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—melanoma	1.32e-05	4.98e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FGF2—melanoma	1.32e-05	4.95e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HIF1A—melanoma	1.32e-05	4.95e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK3—melanoma	1.31e-05	4.94e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNAQ—melanoma	1.31e-05	4.93e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CD44—melanoma	1.31e-05	4.93e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP17A1—melanoma	1.3e-05	4.9e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—BRAF—melanoma	1.29e-05	4.85e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SDHD—melanoma	1.29e-05	4.83e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BSG—melanoma	1.29e-05	4.83e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CSPG4—melanoma	1.29e-05	4.83e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.28e-05	4.83e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.27e-05	4.79e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KDR—melanoma	1.26e-05	4.73e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1B1—melanoma	1.26e-05	4.73e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1—melanoma	1.26e-05	4.72e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK1—melanoma	1.25e-05	4.7e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—melanoma	1.25e-05	4.7e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CD—melanoma	1.25e-05	4.69e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPAM—melanoma	1.24e-05	4.68e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—melanoma	1.24e-05	4.65e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MDM2—melanoma	1.23e-05	4.63e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALB—melanoma	1.23e-05	4.63e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNA11—melanoma	1.23e-05	4.62e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP17A1—melanoma	1.23e-05	4.61e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB2—melanoma	1.21e-05	4.57e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAP2K1—melanoma	1.21e-05	4.56e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FN1—melanoma	1.21e-05	4.56e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CD—melanoma	1.21e-05	4.53e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.21e-05	4.53e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—FASN—melanoma	1.2e-05	4.52e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CB—melanoma	1.2e-05	4.51e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	1.19e-05	4.49e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOTCH1—melanoma	1.19e-05	4.46e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC5A5—melanoma	1.18e-05	4.45e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—melanoma	1.18e-05	4.44e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CD80—melanoma	1.16e-05	4.37e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CG—melanoma	1.16e-05	4.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APC—melanoma	1.16e-05	4.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KIT—melanoma	1.16e-05	4.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NRAS—melanoma	1.16e-05	4.36e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNA11—melanoma	1.16e-05	4.36e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—melanoma	1.16e-05	4.34e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FGF2—melanoma	1.15e-05	4.34e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—melanoma	1.15e-05	4.33e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGF—melanoma	1.15e-05	4.31e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—melanoma	1.14e-05	4.3e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNAQ—melanoma	1.14e-05	4.3e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CD44—melanoma	1.14e-05	4.3e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—FASN—melanoma	1.13e-05	4.26e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1B—melanoma	1.13e-05	4.23e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC5A5—melanoma	1.12e-05	4.19e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—melanoma	1.11e-05	4.18e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK3—melanoma	1.11e-05	4.18e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.11e-05	4.17e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—melanoma	1.1e-05	4.15e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—melanoma	1.1e-05	4.14e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1B1—melanoma	1.1e-05	4.12e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—melanoma	1.1e-05	4.12e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BRAF—melanoma	1.09e-05	4.1e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CB—melanoma	1.09e-05	4.09e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—melanoma	1.08e-05	4.08e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MDM2—melanoma	1.08e-05	4.06e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNAQ—melanoma	1.08e-05	4.05e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CD44—melanoma	1.08e-05	4.05e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—melanoma	1.08e-05	4.05e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—melanoma	1.07e-05	4.04e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—melanoma	1.07e-05	4.01e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CTNNB1—melanoma	1.06e-05	4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—melanoma	1.06e-05	3.99e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLA2G6—melanoma	1.06e-05	3.98e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK1—melanoma	1.06e-05	3.97e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—melanoma	1.06e-05	3.97e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CB—melanoma	1.05e-05	3.95e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—melanoma	1.04e-05	3.92e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1A—melanoma	1.04e-05	3.9e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—melanoma	1.04e-05	3.9e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCB1—melanoma	1.04e-05	3.89e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1B1—melanoma	1.03e-05	3.88e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NFKB1—melanoma	1.03e-05	3.88e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAP2K1—melanoma	1.03e-05	3.86e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CD—melanoma	1.02e-05	3.83e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—melanoma	1.01e-05	3.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—melanoma	1.01e-05	3.8e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	1.01e-05	3.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—melanoma	1e-05	3.77e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—melanoma	9.98e-06	3.75e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1B—melanoma	9.86e-06	3.71e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGF2—melanoma	9.76e-06	3.67e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—melanoma	9.76e-06	3.67e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—melanoma	9.67e-06	3.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—melanoma	9.65e-06	3.63e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—melanoma	9.61e-06	3.61e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—melanoma	9.59e-06	3.6e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PRKCA—melanoma	9.53e-06	3.58e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—VCAN—melanoma	9.51e-06	3.57e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ERCC2—melanoma	9.45e-06	3.55e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—melanoma	9.41e-06	3.54e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—melanoma	9.39e-06	3.53e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—melanoma	9.36e-06	3.52e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CTNNB1—melanoma	9.32e-06	3.5e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—melanoma	9.26e-06	3.48e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRAS—melanoma	9.24e-06	3.48e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—melanoma	9.17e-06	3.45e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—melanoma	9.14e-06	3.44e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MDM2—melanoma	9.13e-06	3.43e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1A—melanoma	9.1e-06	3.42e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—melanoma	9.08e-06	3.42e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NFKB1—melanoma	9.04e-06	3.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—melanoma	9e-06	3.39e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CB—melanoma	8.88e-06	3.34e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—melanoma	8.86e-06	3.33e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK3—melanoma	8.85e-06	3.33e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—melanoma	8.61e-06	3.24e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—melanoma	8.54e-06	3.21e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCB1—melanoma	8.5e-06	3.2e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—melanoma	8.48e-06	3.19e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK1—melanoma	8.42e-06	3.17e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—melanoma	8.42e-06	3.17e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1B—melanoma	8.34e-06	3.13e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PRKCA—melanoma	8.3e-06	3.12e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—melanoma	8.25e-06	3.1e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ERCC2—melanoma	8.24e-06	3.1e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—melanoma	8.2e-06	3.08e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—melanoma	8.17e-06	3.07e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—melanoma	8.16e-06	3.07e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—melanoma	8.15e-06	3.06e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—melanoma	8.12e-06	3.05e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—melanoma	8.12e-06	3.05e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRAS—melanoma	8.1e-06	3.05e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP17A1—melanoma	8.02e-06	3.02e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—melanoma	7.95e-06	2.99e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—melanoma	7.95e-06	2.99e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNB1—melanoma	7.88e-06	2.96e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.83e-06	2.94e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—melanoma	7.83e-06	2.94e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PRKCA—melanoma	7.83e-06	2.94e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ERCC2—melanoma	7.76e-06	2.92e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK3—melanoma	7.76e-06	2.92e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—melanoma	7.72e-06	2.9e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1A—melanoma	7.69e-06	2.89e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—melanoma	7.68e-06	2.89e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NFKB1—melanoma	7.64e-06	2.87e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNA11—melanoma	7.57e-06	2.85e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—melanoma	7.55e-06	2.84e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—melanoma	7.49e-06	2.82e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CG—melanoma	7.47e-06	2.81e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—FASN—melanoma	7.41e-06	2.79e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK1—melanoma	7.38e-06	2.78e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—melanoma	7.38e-06	2.78e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—melanoma	7.31e-06	2.75e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A5—melanoma	7.29e-06	2.74e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—melanoma	7.21e-06	2.71e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—melanoma	7.07e-06	2.66e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNAQ—melanoma	7.04e-06	2.65e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CD44—melanoma	7.04e-06	2.65e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—melanoma	6.97e-06	2.62e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—melanoma	6.93e-06	2.61e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—melanoma	6.87e-06	2.58e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRAS—melanoma	6.85e-06	2.58e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—melanoma	6.76e-06	2.54e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1B1—melanoma	6.75e-06	2.54e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—melanoma	6.66e-06	2.5e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—melanoma	6.62e-06	2.49e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CD—melanoma	6.56e-06	2.47e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK3—melanoma	6.56e-06	2.47e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CG—melanoma	6.5e-06	2.45e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—melanoma	6.48e-06	2.44e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—melanoma	6.47e-06	2.43e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—melanoma	6.41e-06	2.41e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—melanoma	6.38e-06	2.4e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—melanoma	6.28e-06	2.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK1—melanoma	6.24e-06	2.35e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—melanoma	6.24e-06	2.35e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—melanoma	6.2e-06	2.33e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CG—melanoma	6.13e-06	2.3e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—melanoma	5.97e-06	2.24e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—melanoma	5.93e-06	2.23e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—melanoma	5.92e-06	2.22e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—melanoma	5.89e-06	2.22e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CB—melanoma	5.72e-06	2.15e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CD—melanoma	5.72e-06	2.15e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—melanoma	5.67e-06	2.13e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—melanoma	5.67e-06	2.13e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—melanoma	5.64e-06	2.12e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCB1—melanoma	5.56e-06	2.09e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—melanoma	5.42e-06	2.04e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—melanoma	5.41e-06	2.03e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CD—melanoma	5.39e-06	2.03e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—melanoma	5.32e-06	2e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—melanoma	5.24e-06	1.97e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—melanoma	5.23e-06	1.97e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PRKCA—melanoma	5.12e-06	1.92e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ERCC2—melanoma	5.07e-06	1.91e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—melanoma	5.01e-06	1.88e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CB—melanoma	4.98e-06	1.87e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—melanoma	4.94e-06	1.86e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—melanoma	4.94e-06	1.86e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—melanoma	4.8e-06	1.8e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CB—melanoma	4.7e-06	1.77e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—melanoma	4.65e-06	1.75e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—melanoma	4.42e-06	1.66e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—melanoma	4.31e-06	1.62e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—melanoma	4.06e-06	1.53e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CG—melanoma	4.01e-06	1.51e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—melanoma	3.87e-06	1.45e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CD—melanoma	3.52e-06	1.32e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—melanoma	3.49e-06	1.31e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—melanoma	3.48e-06	1.31e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CB—melanoma	3.07e-06	1.15e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—melanoma	3.04e-06	1.14e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—melanoma	3.04e-06	1.14e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—melanoma	2.86e-06	1.08e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—melanoma	2.85e-06	1.07e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—melanoma	2.65e-06	9.98e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—melanoma	2.48e-06	9.33e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—melanoma	2.34e-06	8.8e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—melanoma	1.87e-06	7.04e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—melanoma	1.53e-06	5.75e-06	CbGpPWpGaD
